Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013)

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 7, 2015, Pages 4315-4317

  Simner, P J ^a,b   Adam, H ^a,b   Baxter, M ^b   McCracken, M ^c   Golding, G ^b,c   Karlowsky, J A ^a,b   Nichol, K ^a   Lagace Wiens P ^a,b   Gilmour, M W ^a,b   Hoban, D J ^a,b   Zhanel, G G ^a,b  

^a Diagnostic Services of Manitoba Inc   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DAPTOMYCIN; DOXYCYCLINE; LEVOFLOXACIN; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; LIGASE; VANA LIGASE, BACTERIA; VANB PROTEIN, ENTEROCOCCUS;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANADIAN; CONTROLLED STUDY; EMERGENCY WARD; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITAL; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SURGICAL WARD; TERTIARY CARE CENTER; VANCOMYCIN RESISTANT ENTEROCOCCUS; ADOLESCENT; CANADA; CHILD; DRUG EFFECTS; ENTEROCOCCUS; GENETICS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH SURVEY; INFANT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; NEWBORN; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CANADA; CARBON-OXYGEN LIGASES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; PUBLIC HEALTH SURVEILLANCE; VANCOMYCIN; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 84931292097     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00384-15     Document Type: Article

References (15)

1. Arias CA, Contreras GA, Murray BE. 2010. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect 16:555-562. http://dx.doi.org/10.1111/j.1469-0691.2010.03214.x.
2. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. 2007. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 58:163-170. http://dx.doi.org/10.1016/j.diagmicrobio.2006.12.022.
3. Lu CL, Chuang YC, Chang HC, Chen YC, Wang JT, Chang SC. 2012. Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis. J Antimicrob Chemother 67:2243-2249. http://dx.doi.org/10.1093/jac/dks181.
4. Reik R, Tenover FC, Klein E, McDonald LC. 2008. The burden of vancomycin-resistant enterococcal infections in U.S. hospitals, 2003 to 2004. Diagn Microbiol Infect Dis 62:81-85. http://dx.doi.org/10.1016/j.diagmicrobio.2008.04.013.
5. Ramsey AM, Zilberberg MD. 2009. Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000- 2006. Infect Control Hosp Epidemiol 30:184-186. http://dx.doi.org/10.1086/593956.
6. Kibsey PC, Willey B, Low DE. 1993. Vancomycin multi-resistant Enterococcus faecium: first Canadian isolate, abstr K5. Abstr Can Assoc Clin Microbiol Infect Dis, 21 to 25 November 1993, Vancouver, British Columbia, Canada.
7. Ofner-Agostini ME, Conly J, Paton S, Kureishi A, Nicolle L, Mulvey M, Johnson W, Johnston L, Canadian Hospital Epidemiology Committee. 1997. Vancomycin-resistant enterococci (VRE) in Canada-results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project. Can J Infect Dis 8:73-78.
8. Zhanel GG, Decorby M, Nichol KA, Baudry PJ, Karlowsky JA, Lagace-Wiens PR, McCracken M, Mulvey MR, Hoban DJ. 2008. Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006). Can J Infect Dis Med Microbiol 19:243-249.
9. McCracken M, Wong A, Mitchell R, Gravel D, Conly J, Embil J, Johnston L, Matlow A, Ormiston D, Simor AE, Smith S, Du T, Hizon R, Mulvey MR, Canadian Nosocomial Infection Surveillance Program. 2013. Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009. J Antimicrob Chemother 68:1505-1509. http://dx.doi.org/10.1093/jac/dkt054.
10. Zhanel GG, Adam HJ, Baxter MR, Fuller J, Nichol KA, Denisuik AJ, Lagace-Wiens PR, Walkty A, Karlowsky JA, Schweizer F, Hoban DJ, Canadian Antimicrobial Resistance Alliance. 2013. Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study. J Antimicrob Chemother 68(Suppl 1):i7-i22. http://dx.doi.org/10.1093/jac/dkt022.
11. th informational supplement. CLSI M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Jia XQ, Pang F, Chen JZ, Jiang LX. 2015. Prevalence and clinical distribution of multidrug-resistant bacteria (3537 isolates) in a tertiary Chinese hospital (January 2012-December 2013). Pathol Biol (Paris) 63:21-23. http://dx.doi.org/10.1016/j.patbio.2014.12.002.
13. Denkinger CM, Grant AD, Denkinger M, Gautam S, D'Agata EM. 2012. Increased multi-drug resistance among the elderly on admission to the hospital-a 12-year surveillance study. Arch Gerontol Geriatr 56:227-230. http://dx.doi.org/10.1016/j.archger.2012.05.006.
14. Boyd DA, Willey BM, Fawcett D, Gillani N, Mulvey MR. 2008. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents Chemother 52:2667-2672. http://dx.doi.org/10.1128/AAC.01516-07.
15. Kang M, Xie Y, He C, Chen ZX, Guo L, Yang Q, Liu JY, Du Y, Ou QS, Wang LL. 2014. Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China. Eur J Clin Microbiol Infect Dis 33:933-939. http://dx.doi.org/10.1007/s10096-013-2029-z.